edaravone prodrug (TEJ-1704)
/ J2HBiotech, Theragen Etex
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 29, 2021
Pre-Clinical Pharmacokinetic Characterization, Tissue Distribution, and Excretion Studies of Novel Edaravone Oral Prodrug, TEJ-1704.
(PubMed, Pharmaceutics)
- "The pharmacokinetics, tissue distribution, and excretion of TEJ-1704, a novel edaravone oral prodrug, were successfully characterized. Additional studies are needed to fully understand the difference between TEJ-1704 and edaravone and determine the potency of TEJ-1704."
Journal • PK/PD data • Preclinical • Amyotrophic Lateral Sclerosis • CNS Disorders
1 to 1
Of
1
Go to page
1